The EpiPen litigation is a defining example of how state attorneys general take on powerful pharmaceutical companies to protect public interest. Dramatic price increases, alleged antitrust violations, and deceptive marketing practices have created a substantial financial burden for families and strained state healthcare budgets. By spearheading investigations and bringing lawsuits against the makers of EpiPen,… Read more
